Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam de la Torre

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Facial Plastic Surgery : FPS|June 14, 2013
Use of fractional laser in mixed-race patientsRafael Espinosa Delgado, Miriam de la Torre
Facial Plastic Surgery Clinics of North America|November 4, 2024
Skin-Tightening Devices (Radiofrequency) in Mixed-Race PatientsRafael Espinosa Delgado, Miriam de la Torre Campos
International Journal of Molecular Sciences|November 11, 2022
Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended LifespanLaura Moreno-Martinez, Llipsy Santiago, Miriam de la Torre, et al.
Neuro-Degenerative Diseases|August 22, 2016
Granulocyte Colony-Stimulating Factor Ameliorates Skeletal Muscle Dysfunction in Amyotrophic Lateral Sclerosis Mice and Improves Proliferation of SOD1-G93A Myoblasts in vitroAmaya Rando, Samanta Gasco, Miriam de la Torre, et al.
Behavioral Sciences (Basel, Switzerland)|October 27, 2023
Self-Determined Regulation, Achievement Goals and Sport Commitment in Spanish Masters SwimmersJuan Ángel Simón-Piqueras, Pedro Gil-Madrona, David Zamorano-García, et al.
Toxins|May 21, 2020
Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse ModelLaura Moreno-Martinez, Miriam de la Torre, María J Muñoz, et al.
Frontiers in Immunology|April 30, 2019
Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral SclerosisLaura Moreno-Martínez, Miriam de la Torre, Janne M Toivonen, et al.
Plos One|January 15, 2019
Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALSAmaya Rando, Miriam de la Torre, Anna Martinez-Muriana, et al.
BMC Genomics|July 2, 2025
Circular RNA expression in ALS is progressively deregulated and tissue-dependentLeticia Moreno-García, Laura Moreno-Martínez, Miriam de la Torre, et al.
International Journal of Molecular Sciences|April 3, 2021
Inflammasome in ALS Skeletal Muscle: <i>NLRP3</i> as a Potential BiomarkerLeticia Moreno-García, Francisco J Miana-Mena, Laura Moreno-Martínez, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Facial Plastic Surgery : FPS|June 14, 2013
Use of fractional laser in mixed-race patientsRafael Espinosa Delgado, Miriam de la Torre
Facial Plastic Surgery Clinics of North America|November 4, 2024
Skin-Tightening Devices (Radiofrequency) in Mixed-Race PatientsRafael Espinosa Delgado, Miriam de la Torre Campos
International Journal of Molecular Sciences|November 11, 2022
Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended LifespanLaura Moreno-Martinez, Llipsy Santiago, Miriam de la Torre, et al.
Neuro-Degenerative Diseases|August 22, 2016
Granulocyte Colony-Stimulating Factor Ameliorates Skeletal Muscle Dysfunction in Amyotrophic Lateral Sclerosis Mice and Improves Proliferation of SOD1-G93A Myoblasts in vitroAmaya Rando, Samanta Gasco, Miriam de la Torre, et al.
Behavioral Sciences (Basel, Switzerland)|October 27, 2023
Self-Determined Regulation, Achievement Goals and Sport Commitment in Spanish Masters SwimmersJuan Ángel Simón-Piqueras, Pedro Gil-Madrona, David Zamorano-García, et al.
Toxins|May 21, 2020
Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse ModelLaura Moreno-Martinez, Miriam de la Torre, María J Muñoz, et al.
Frontiers in Immunology|April 30, 2019
Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral SclerosisLaura Moreno-Martínez, Miriam de la Torre, Janne M Toivonen, et al.
Plos One|January 15, 2019
Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALSAmaya Rando, Miriam de la Torre, Anna Martinez-Muriana, et al.
BMC Genomics|July 2, 2025
Circular RNA expression in ALS is progressively deregulated and tissue-dependentLeticia Moreno-García, Laura Moreno-Martínez, Miriam de la Torre, et al.
International Journal of Molecular Sciences|April 3, 2021
Inflammasome in ALS Skeletal Muscle: <i>NLRP3</i> as a Potential BiomarkerLeticia Moreno-García, Francisco J Miana-Mena, Laura Moreno-Martínez, et al.
Pageof 2